Vectorized antibodies hold promise to overcome many of these limitations and provide a great opportunity for DNA and RNA technology companies to enter larger markets compared with the rare disease ...
Please provide your email address to receive an email when new articles are posted on . VTx-002 targets proteins that play a significant role in neurodegenerative disease. Enrollment in and ...
Vectorized Inc., a new data management startup, today disclosed that it has raised $15.5 million across two funding rounds from Lightspeed Venture Partners and Alphabet Inc.’s GV fund. The startup’s ...
A year after AbbVie and Voyager Therapeutics teamed up on Alzheimer’s disease, they are expanding their partnership to include Parkinson’s disease and other diseases in which misfolded alpha-synuclein ...
SAN FRANCISCO, Jan. 26, 2021 (GLOBE NEWSWIRE) -- Vectorized, Inc., the Intelligent Data API company, today announced the general availability of Redpanda, the Intelligent Data API Platform. Vectorized ...
ORLANDO, Fla.--(BUSINESS WIRE)--Encoded Therapeutics Inc., a clinical-stage biotechnology company developing genetic medicines for severe central nervous system (CNS) disorders, announced today that ...
Not all drug targets are created equal. For those that result in a tissue-specific gain-of-function, the strategy can be not-so-straightforward. That’s exactly what’s going on in some forms of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results